|S-1/AJan 7, 4:20 PM ET

Elixir Pharmaceuticals, Inc. S-1/A

S-1/A · Elixir Pharmaceuticals, Inc. · Filed Jan 7, 2008

Documents

7 files
  • S-1

    AMENDMENT #5 TO FORM S-1

  • EX-1.1

    UNDERWRITING AGREEMENT

  • EX-10.38

    LICENSE AGREEMENT WITH BRISTOL-MYERS SQUIBB COMPANY

  • EX-10.39

    EXCLUSIVE LICENSE AGREEMENT ON MITIGLINIDE WITH KISSEI PHARMACEUTICAL CO. LTD

  • EX-10.41

    BINDING AGREEMENT BETWEEN NOVARTIS INTERNATIONAL PHARMACEUTICALS AND ELIXIR PHAR

  • EX-23.1

    CONSENT OF ERNST & YOUNG LLP

  • GRAPHIC
    g21963image001.jpg

    GRAPHIC